 | • レポートコード：MRC2-11QY12015 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：New Technology |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は遺伝子編集のグローバル市場について調査・分析したレポートです。種類別（ジンクフィンガーヌクレアーゼ（ZFN）、転写活性化因子様エフェクターベースのヌクレアーゼ（TALEN）、CRISPR-Casシステム）市場規模、用途別（バイオテクノロジー・製薬会社、学術・政府研究所、委託研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別遺伝子編集の競争状況、市場シェア ・世界の遺伝子編集市場：種類別市場規模 2015年-2020年（ジンクフィンガーヌクレアーゼ（ZFN）、転写活性化因子様エフェクターベースのヌクレアーゼ（TALEN）、CRISPR-Casシステム） ・世界の遺伝子編集市場：種類別市場規模予測 2021年-2026年（ジンクフィンガーヌクレアーゼ（ZFN）、転写活性化因子様エフェクターベースのヌクレアーゼ（TALEN）、CRISPR-Casシステム） ・世界の遺伝子編集市場：用途別市場規模 2015年-2020年（バイオテクノロジー・製薬会社、学術・政府研究所、委託研究機関） ・世界の遺伝子編集市場：用途別市場規模予測 2021年-2026年（バイオテクノロジー・製薬会社、学術・政府研究所、委託研究機関） ・北米の遺伝子編集市場分析：米国、カナダ ・ヨーロッパの遺伝子編集市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの遺伝子編集市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の遺伝子編集市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの遺伝子編集市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Merck、Horizon Discovery、Sangamo BioSciences、Integrated DNA Technologies、Lonza、New England Biolabs、OriGene Technologies、Transposagen Biopharmaceuticals、Editas Medicine、CRISPR Therapeutics、RGen Solutions、Sigma-Aldrich、GeneCopoeia、Genscript Biotech、OriGene Technologies、Agilent Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Market Analysis and Insights: Global Gene Editing Market
The global Gene Editing market size is projected to reach US$ 3188.8 million by 2026, from US$ 2936.8 million in 2020, at a CAGR of 7.9%% during 2021-2026.
Global Gene Editing Scope and Market Size
Gene Editing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Editing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
OriGene Technologies
Agilent Technologies
Market segment by Type, the product can be split into
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Market segment by Application, split into
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Editing Revenue
1.4 Market by Type
1.4.1 Global Gene Editing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Zinc finger nucleases (ZFNs)
1.4.3 Transcription Activator-Like Effector-based Nucleases (TALENs)
1.4.4 CRISPR-Cas system
1.5 Market by Application
1.5.1 Global Gene Editing Market Share by Application: 2020 VS 2026
1.5.2 Biotechnology & Pharmaceutical Companies
1.5.3 Academic & Government Research Institutes
1.5.4 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gene Editing Market Perspective (2015-2026)
2.2 Global Gene Editing Growth Trends by Regions
2.2.1 Gene Editing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Editing Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Competition Landscape by Key Players
3.1 Gene Editing Revenue by Players (2019-2020)
3.2 Gene Editing Key Players Head office and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Key Players Gene Editing Funding/Investment Analysis
3.6 Global Key Players Gene Editing Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans
4 Global Gene Editing Market Size by Type (2019-2026)
5 Global Gene Editing Market Size by Application (2019-2026)
6 North America
6.1 North America Gene Editing Market Forecast (2019-2026)
6.2 Gene Editing Key Players in North America (2019-2020)
6.3 North America Gene Editing Market Size by Type (2015-2020)
6.4 North America Gene Editing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gene Editing Market Forecast (2019-2026)
7.2 Gene Editing Key Players in Europe (2019-2020)
7.3 Europe Gene Editing Market Size by Type (2015-2020)
7.4 Europe Gene Editing Market Size by Application (2015-2020)
8 China
8.1 China Gene Editing Market Forecast (2019-2026)
8.2 Gene Editing Key Players in China (2019-2020)
8.3 China Gene Editing Market Size by Type (2015-2020)
8.4 China Gene Editing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gene Editing Market Forecast (2019-2026)
9.2 Gene Editing Key Players in Japan (2019-2020)
9.3 Japan Gene Editing Market Size by Type (2015-2020)
9.4 Japan Gene Editing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gene Editing Market Forecast (2019-2026)
10.2 Gene Editing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Editing Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Editing Market Size by Application (2015-2020)
11 India
11.1 India Gene Editing Market Forecast (2019-2026)
11.2 Gene Editing Key Players in India (2019-2020)
11.3 India Gene Editing Market Size by Type (2015-2020)
11.4 India Gene Editing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gene Editing Market Forecast (2019-2026)
12.2 Gene Editing Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Editing Market Size by Type (2015-2020)
12.4 Central & South America Gene Editing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific Gene Editing Introduction
13.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2019-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Gene Editing Introduction
13.2.4 Merck Revenue in Gene Editing Business (2019-2020))
13.2.5 Merck Recent Development
13.3 Horizon Discovery
13.3.1 Horizon Discovery Company Details
13.3.2 Horizon Discovery Business Overview
13.3.3 Horizon Discovery Gene Editing Introduction
13.3.4 Horizon Discovery Revenue in Gene Editing Business (2019-2020))
13.3.5 Horizon Discovery Recent Development
13.4 Sangamo BioSciences
13.4.1 Sangamo BioSciences Company Details
13.4.2 Sangamo BioSciences Business Overview
13.4.3 Sangamo BioSciences Gene Editing Introduction
13.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2019-2020))
13.4.5 Sangamo BioSciences Recent Development
13.5 Integrated DNA Technologies
13.5.1 Integrated DNA Technologies Company Details
13.5.2 Integrated DNA Technologies Business Overview
13.5.3 Integrated DNA Technologies Gene Editing Introduction
13.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2019-2020))
13.5.5 Integrated DNA Technologies Recent Development
13.6 Lonza
13.6.1 Lonza Company Details
13.6.2 Lonza Business Overview
13.6.3 Lonza Gene Editing Introduction
13.6.4 Lonza Revenue in Gene Editing Business (2019-2020))
13.6.5 Lonza Recent Development
13.7 New England Biolabs
13.7.1 New England Biolabs Company Details
13.7.2 New England Biolabs Business Overview
13.7.3 New England Biolabs Gene Editing Introduction
13.7.4 New England Biolabs Revenue in Gene Editing Business (2019-2020))
13.7.5 New England Biolabs Recent Development
13.8 OriGene Technologies
13.8.1 OriGene Technologies Company Details
13.8.2 OriGene Technologies Business Overview
13.8.3 OriGene Technologies Gene Editing Introduction
13.8.4 OriGene Technologies Revenue in Gene Editing Business (2019-2020))
13.8.5 OriGene Technologies Recent Development
13.9 Transposagen Biopharmaceuticals
13.9.1 Transposagen Biopharmaceuticals Company Details
13.9.2 Transposagen Biopharmaceuticals Business Overview
13.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction
13.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2019-2020))
13.9.5 Transposagen Biopharmaceuticals Recent Development
13.10 Editas Medicine
13.10.1 Editas Medicine Company Details
13.10.2 Editas Medicine Business Overview
13.10.3 Editas Medicine Gene Editing Introduction
13.10.4 Editas Medicine Revenue in Gene Editing Business (2019-2020))
13.10.5 Editas Medicine Recent Development
13.11 CRISPR Therapeutics
10.11.1 CRISPR Therapeutics Company Details
10.11.2 CRISPR Therapeutics Business Overview
10.11.3 CRISPR Therapeutics Gene Editing Introduction
10.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2019-2020))
10.11.5 CRISPR Therapeutics Recent Development
13.12 RGen Solutions
10.12.1 RGen Solutions Company Details
10.12.2 RGen Solutions Business Overview
10.12.3 RGen Solutions Gene Editing Introduction
10.12.4 RGen Solutions Revenue in Gene Editing Business (2019-2020))
10.12.5 RGen Solutions Recent Development
13.13 Sigma-Aldrich
10.13.1 Sigma-Aldrich Company Details
10.13.2 Sigma-Aldrich Business Overview
10.13.3 Sigma-Aldrich Gene Editing Introduction
10.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2019-2020))
10.13.5 Sigma-Aldrich Recent Development
13.14 GeneCopoeia
10.14.1 GeneCopoeia Company Details
10.14.2 GeneCopoeia Business Overview
10.14.3 GeneCopoeia Gene Editing Introduction
10.14.4 GeneCopoeia Revenue in Gene Editing Business (2019-2020))
10.14.5 GeneCopoeia Recent Development
13.15 Genscript Biotech
10.15.1 Genscript Biotech Company Details
10.15.2 Genscript Biotech Business Overview
10.15.3 Genscript Biotech Gene Editing Introduction
10.15.4 Genscript Biotech Revenue in Gene Editing Business (2019-2020))
10.15.5 Genscript Biotech Recent Development
13.16 OriGene Technologies
10.16.1 OriGene Technologies Company Details
10.16.2 OriGene Technologies Business Overview
10.16.3 OriGene Technologies Gene Editing Introduction
10.16.4 OriGene Technologies Revenue in Gene Editing Business (2019-2020))
10.16.5 OriGene Technologies Recent Development
13.17 Agilent Technologies
10.17.1 Agilent Technologies Company Details
10.17.2 Agilent Technologies Business Overview
10.17.3 Agilent Technologies Gene Editing Introduction
10.17.4 Agilent Technologies Revenue in Gene Editing Business (2019-2020))
10.17.5 Agilent Technologies Recent Development
14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porter’s Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis
15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gene Editing Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Editing Revenue
Table 3. Ranking of Global Top Gene Editing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Editing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Zinc finger nucleases (ZFNs)
Table 6. Key Players of Transcription Activator-Like Effector-based Nucleases (TALENs)
Table 7. Key Players of CRISPR-Cas system
Table 8. Global Gene Editing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Gene Editing Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Gene Editing Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Gene Editing Market Share by Regions 2019-2026
Table 12. Market Top Trends
Table 13. Market Use Cases
Table 14. Global Gene Editing Revenue by Players (2019-2020) (Million US$)
Table 15. Global Gene Editing Market Share by Players (2019-2020)
Table 16. Key Players Headquarters and Area Served
Table 17. Key Players Gene Editing Product Solution and Service
Table 18. Date of Enter into Gene Editing Market
Table 19. Global Key Players Gene Editing Funding/Investment Analysis (Million USD)
Table 20. Global Key Players Gene Editing Valuation & Market Capitalization (Million USD)
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 23. Global Gene Editing Market Size Share by Type (2019-2026)
Table 24. Global Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 25. Global Gene Editing Market Size Share by Application (2019-2026)
Table 26. North America Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 27. North America Key Players Gene Editing Market Share (2019-2020)
Table 28. North America Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 29. North America Gene Editing Market Share by Type (2019-2026)
Table 30. North America Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 31. North America Gene Editing Market Share by Application (2019-2026)
Table 32. Europe Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 33. Europe Key Players Gene Editing Market Share (2019-2020)
Table 34. Europe Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 35. Europe Gene Editing Market Share by Type (2019-2026)
Table 36. Europe Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 37. Europe Gene Editing Market Share by Application (2019-2026)
Table 38. China Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 39. China Key Players Gene Editing Market Share (2019-2020)
Table 40. China Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 41. China Gene Editing Market Share by Type (2019-2026)
Table 42. China Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 43. China Gene Editing Market Share by Application (2019-2026)
Table 44. Japan Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 45. Japan Key Players Gene Editing Market Share (2019-2020)
Table 46. Japan Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 47. Japan Gene Editing Market Share by Type (2019-2026)
Table 48. Japan Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 49. Japan Gene Editing Market Share by Application (2019-2026)
Table 50. Southeast Asia Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 51. Southeast Asia Key Players Gene Editing Market Share (2019-2020)
Table 52. Southeast Asia Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 53. Southeast Asia Gene Editing Market Share by Type (2019-2026)
Table 54. Southeast Asia Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 55. Southeast Asia Gene Editing Market Share by Application (2019-2026)
Table 56. India Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 57. India Key Players Gene Editing Market Share (2019-2020)
Table 58. India Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 59. India Gene Editing Market Share by Type (2019-2026)
Table 60. India Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 61. India Gene Editing Market Share by Application (2019-2026)
Table 62. Central & South America Key Players Gene Editing Revenue (2019-2020) (Million US$)
Table 63. Central & South America Key Players Gene Editing Market Share (2019-2020)
Table 64. Central & South America Gene Editing Market Size by Type (2019-2026) (Million US$)
Table 65. Central & South America Gene Editing Market Share by Type (2019-2026)
Table 66. Central & South America Gene Editing Market Size by Application (2019-2026) (Million US$)
Table 67. Central & South America Gene Editing Market Share by Application (2019-2026)
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Product
Table 71. Company Description and Business Overview
Table 72. Thermo Fisher Scientific Gene Editing Product
Table 73. Thermo Fisher Scientific Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 74. Thermo Fisher Scientific Recent Development
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Company Description and Business Overview
Table 79. Merck Gene Editing Product
Table 80. Merck Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 81. Merck Recent Development
Table 82. Horizon Discovery Company Details
Table 83. Horizon Discovery Business Overview
Table 84. Horizon Discovery Product
Table 85. Company Description and Business Overview
Table 86. Horizon Discovery Gene Editing Product
Table 87. Horizon Discovery Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 88. Horizon Discovery Recent Development
Table 89. Sangamo BioSciences Company Details
Table 90. Sangamo BioSciences Business Overview
Table 91. Sangamo BioSciences Product
Table 92. Company Description and Business Overview
Table 93. Sangamo BioSciences Gene Editing Product
Table 94. Sangamo BioSciences Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 95. Sangamo BioSciences Recent Development
Table 96. Integrated DNA Technologies Company Details
Table 97. Integrated DNA Technologies Business Overview
Table 98. Integrated DNA Technologies Product
Table 99. Company Description and Business Overview
Table 100. Integrated DNA Technologies Gene Editing Product
Table 101. Integrated DNA Technologies Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 102. Integrated DNA Technologies Recent Development
Table 103. Lonza Company Details
Table 104. Lonza Business Overview
Table 105. Lonza Product
Table 106. Company Description and Business Overview
Table 107. Lonza Gene Editing Product
Table 108. Lonza Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 109. Lonza Recent Development
Table 110. New England Biolabs Company Details
Table 111. New England Biolabs Business Overview
Table 112. New England Biolabs Product
Table 113. Company Description and Business Overview
Table 114. New England Biolabs Gene Editing Product
Table 115. New England Biolabs Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 116. New England Biolabs Recent Development
Table 117. OriGene Technologies Business Overview
Table 118. OriGene Technologies Product
Table 119. OriGene Technologies Company Details
Table 120. Company Description and Business Overview
Table 121. OriGene Technologies Gene Editing Product
Table 122. OriGene Technologies Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 123. OriGene Technologies Recent Development
Table 124. Transposagen Biopharmaceuticals Company Details
Table 125. Transposagen Biopharmaceuticals Business Overview
Table 126. Transposagen Biopharmaceuticals Product
Table 127. Company Description and Business Overview
Table 128. Transposagen Biopharmaceuticals Gene Editing Product
Table 129. Transposagen Biopharmaceuticals Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 130. Transposagen Biopharmaceuticals Recent Development
Table 131. Editas Medicine Company Details
Table 132. Editas Medicine Business Overview
Table 133. Editas Medicine Product
Table 134. Company Description and Business Overview
Table 135. Editas Medicine Gene Editing Product
Table 136. Editas Medicine Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 137. Editas Medicine Recent Development
Table 138. CRISPR Therapeutics Company Details
Table 139. CRISPR Therapeutics Business Overview
Table 140. CRISPR Therapeutics Product
Table 141. Company Description and Business Overview
Table 142. CRISPR Therapeutics Gene Editing Product
Table 143. CRISPR Therapeutics Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 144. CRISPR Therapeutics Recent Development
Table 145. RGen Solutions Company Details
Table 146. RGen Solutions Business Overview
Table 147. RGen Solutions Product
Table 148. Company Description and Business Overview
Table 149. RGen Solutions Gene Editing Product
Table 150. RGen Solutions Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 151. RGen Solutions Recent Development
Table 152. Sigma-Aldrich Company Details
Table 153. Sigma-Aldrich Business Overview
Table 154. Sigma-Aldrich Product
Table 155. Company Description and Business Overview
Table 156. Sigma-Aldrich Gene Editing Product
Table 157. Sigma-Aldrich Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 158. Sigma-Aldrich Recent Development
Table 159. GeneCopoeia Company Details
Table 160. GeneCopoeia Business Overview
Table 161. GeneCopoeia Product
Table 162. Company Description and Business Overview
Table 163. GeneCopoeia Gene Editing Product
Table 164. GeneCopoeia Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 165. GeneCopoeia Recent Development
Table 166. Genscript Biotech Company Details
Table 167. Genscript Biotech Business Overview
Table 168. Genscript Biotech Product
Table 169. Company Description and Business Overview
Table 170. Genscript Biotech Gene Editing Product
Table 171. Genscript Biotech Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 172. Genscript Biotech Recent Development
Table 173. OriGene Technologies Company Details
Table 174. OriGene Technologies Business Overview
Table 175. OriGene Technologies Product
Table 176. Company Description and Business Overview
Table 177. OriGene Technologies Gene Editing Product
Table 178. OriGene Technologies Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 179. OriGene Technologies Recent Development
Table 180. Agilent Technologies Company Details
Table 181. Agilent Technologies Business Overview
Table 182. Agilent Technologies Product
Table 183. Company Description and Business Overview
Table 184. Agilent Technologies Gene Editing Product
Table 185. Agilent Technologies Revenue in Gene Editing Business 2019 and 2020 (Million US$)
Table 186. Agilent Technologies Recent Development
Table 187. Company Description and Business Overview
Table 188. Company Description and Business Overview
Table 189. Company Description and Business Overview
Table 190. Company Description and Business Overview
Table 191. Company Description and Business Overview
Table 192. Company Description and Business Overview
Table 193. Company Description and Business Overview
Table 194. Company Description and Business Overview
Table 195. Company Description and Business Overview
Table 196. Company Description and Business Overview
Table 197. Company Description and Business Overview
Table 198. Company Description and Business Overview
Table 199. Company Description and Business Overview
Table 200. Company Description and Business Overview
Table 201. Company Description and Business Overview
Table 202. Company Description and Business Overview
Table 203. Company Description and Business Overview
Table 204. Company Description and Business Overview
Table 205. Company Description and Business Overview
Table 206. Company Description and Business Overview
Table 207. Company Description and Business Overview
Table 208. Company Description and Business Overview
Table 209. Company Description and Business Overview
Table 210. Key Drivers: Impact Analysis (2021-2026)
Table 211. Key Opportunities
Table 212. Key Challenges
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Editing Market Share by Type: 2020 VS 2026
Figure 2. Zinc finger nucleases (ZFNs) Features
Figure 3. Transcription Activator-Like Effector-based Nucleases (TALENs) Features
Figure 4. CRISPR-Cas system Features
Figure 5. Global Gene Editing Market Share by Application: 2020 VS 2026
Figure 6. Biotechnology & Pharmaceutical Companies Case Studies
Figure 7. Academic & Government Research Institutes Case Studies
Figure 8. Contract Research Organizations Case Studies
Figure 9. Gene Editing Report Years Considered
Figure 10. Global Gene Editing and Growth Rate (2019-2026) (Million US$)
Figure 11. Global Gene Editing Market Share by Regions (2019-2026)
Figure 12. Global Gene Editing Market Share by Players in 2019
Figure 13. Global Gene Editing Market Size Market Share by Type (2019-2026)
Figure 14. Global Gene Editing Market Size Market Share by Application (2019-2026)
Figure 15. North America Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. Europe Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. China Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Japan Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. Southeast Asia Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. India Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Central & South America Gene Editing Market Size YoY Growth (2019-2026) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
ゲノム編集の世界市場（～2026年） Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific doub…- 遺伝子デリバリーシステムの世界市場（～2026年） Gene delivery systems are used to deliver therapeutic drugs targeting a specific area. Gene delivery is a procedure that introduces foreign DNA into host cells. Market Analysis and Insights: Global Gene Delivery System Market The global Gene Delivery System market size is projected to reach US$ 2314…
- ムコ多糖症（MPS）遺伝子治療の世界市場（～2026年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …
- 遺伝子発現の世界市場（～2026年） Gene expression is the process by which information from a gene is used in the synthesis of a functional gene product. These products are often proteins, but in non-protein coding genes such as transfer RNA (tRNA) or small nuclear RNA (snRNA) genes, the product is a functional RNA. Market is expecte…
- DNA遺伝子チップの世界市場（～2026年） DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence…